cyclosporine has been researched along with Cardiomegaly in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (19.23) | 18.2507 |
2000's | 32 (61.54) | 29.6817 |
2010's | 10 (19.23) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, JT; Cheng, KC; Cheng, YZ; Kuo, SC; Lee, WJ; Li, Y | 1 |
Cai, Y; Chen, S; Feng, X; Gao, S; Huang, X; Li, H; Li, Q; Liu, P; Liu, Z; Lu, J; Ye, J | 1 |
Bin, J; Cao, S; Chen, C; Huang, X; Kitakaze, M; Li, G; Li, X; Liao, Y; Shen, L; Xu, D; Xuan, W; Zhang, J | 1 |
Bao, Y; Cai, B; Chen, S; Gao, J; Jiang, J; Le, K; Li, R; Liu, P; Zhang, F | 1 |
Ascah, A; Bourcier-Lucas, C; Burelle, Y; Deschepper, CF; Marcil, M; Matas, J; Young, NT | 1 |
Brum, PC; Ferreira, JC; Gomes, ER; Guatimosim, S; Medeiros, A; Oliveira, RS; Paixão, NA; Rolim, NP | 1 |
Benito, B; Nattel, S | 1 |
Erikson, JM; Lindsey, ML; Zhang, J | 1 |
Bian, ZY; Cao, F; Huang, H; Jiang, H; Li, H; Liu, C; Shen, DF; Tang, QZ; Wang, L; Yan, L; Zhu, LH | 1 |
Chen, C; Chu, X; Dong, DL; Hu, JT; Huang, W; Huo, R; Li, Z; Tu, YJ; Wang, N; Yang, BF | 1 |
Hu, WC; Liu, XH; Rong, F; Wu, XD; Zhang, ZY | 1 |
Dai, J; Gomes, AP; Hafner, AV; Palmeira, CM; Rosenzweig, A; Sinclair, DA; Xiao, CY | 1 |
Dhandapany, PS; Fabris, F; Gelb, BD; Hajjar, RJ; Illaste, A; Karakikes, I; Lebeche, D; Sheng, J; Sobie, EA; Sorourian, M; Tartaglia, M; Tonk, R | 1 |
Bupha-Intr, T; Haizlip, KM; Janssen, PM | 1 |
Radio, SJ; Roberts, CA; Stern, DL | 1 |
Hudnall, SD | 1 |
Duff, HJ; Kryski, AJ; Molkentin, JD; Semeniuk, LM; Severson, DL; Swirp, SL | 1 |
Jordan, MC; Nicholas, SB; Philipson, KD; Quednau, BD; Roos, KP; Ross, RS | 1 |
Boerrigter, G; Burnett, JC; Cataliotti, A; Costello-Boerrigter, LC; Jougasaki, M; Lee, SC; McGregor, CG; Nordstrom, LJ; Salz-Gilman, L; Tsuruda, T | 1 |
Dollinger, MM; Flapan, AD; Hayes, PC; Plevris, JN; Therapondos, G | 1 |
Fu, M; Liu, N; Pang, Y; Tang, C; Xu, S; Zhang, J | 1 |
Bauer, A; Becker, R; Katus, HA; Kelemen, K; Kraft, P; Schoels, W; Schreiner, KD; Senges, JC; Voss, F; Zehelein, J | 1 |
Han, Z; Xiang, J; Yang, Y; Zhang, K | 1 |
Feng, W; Jiang, Y; Kang, YJ; Merten, KE | 1 |
Dong, LF; Wang, YL; Zhang, YJ | 1 |
Barinaga, M | 1 |
Colbert, MC; Gualberto, A; Gude, N; Lim, HW; Molkentin, JD; Olson, EN; Robbins, J; Sussman, MA; Taigen, T; Wieczorek, DF | 1 |
Gualberto, A; Luo, Z; Shyu, KG; Walsh, K | 1 |
Crabtree, GR | 1 |
Horiuchi, M; Jalil, A; Kobayashi, K; Nomoto, M; Saheki, T | 1 |
Choukroun, G; Force, T; Hajjar, R; Rosenzweig, A | 1 |
McKinsey, TA; Olson, EN | 1 |
McCullagh, KJ; Musarò, A; Naya, FJ; Olson, EN; Rosenthal, N | 1 |
Condorelli, G; De Windt, LJ; Dorn, GW; Kitsis, RN; Lim, HW; Molkentin, JD; Taigen, T; Wencker, D | 1 |
De Windt, LJ; Kimball, TR; Lim, HW; Mante, J; Molkentin, JD; Sussman, MA; Witt, SA | 1 |
De Windt, LJ; Kimball, TR; Lim, HW; Molkentin, JD; Steinberg, L; Taigen, T; Witt, SA | 1 |
Attramadal, H; Bjørnerheim, R; Clausen, OP; Oie, E | 1 |
Davisson, RL; Hill, JA; Karimi, M; Kerber, RE; Kutschke, W; Wang, Z; Weiss, RM; Zimmerman, K | 1 |
Fu, M; Liu, N; Pang, Y; Su, J; Tang, C; Xu, S; Zhang, J | 1 |
Brenot, R; Charve, P; David, M; Eicher, JC; Fenot, P; Gomez, MC; Jazayeri, S; Tatou, E | 1 |
Brunner, HR; Murat, A; Pedrazzini, T; Pellieux, C | 1 |
Molkentin, JD | 1 |
Honda, R; Lalli, MJ; Molkentin, JD; Tymitz, KM; Yatani, A | 1 |
Leinwand, LA | 1 |
Han, J; Lim, HW; Molkentin, JD; New, L | 1 |
Fu, MG; Jiang, ZS; Liu, NK; Pang, YZ; Tang, CS; Wang, XH | 1 |
Hill, JA; Karimi, M; Kutschke, W; Richardson, KE; Wang, Z | 1 |
Bauerlein, R; Bodine, SC; Glass, DJ; Gonzalez, M; Kline, WO; Lawrence, JC; Scrimgeour, A; Stitt, TN; Stover, GL; Yancopoulos, GD; Zlotchenko, E | 1 |
Buttrick, PM; Geenen, DL; Goldspink, PH; Kimball, VA; McKinney, RD | 1 |
Demura, M; Mabuchi, H; Takeda, Y; Usukura, M; Yoneda, T | 1 |
Bueno, OF; De Windt, LJ; Doevendans, PA; Molkentin, JD; van Rooij, E | 1 |
6 review(s) available for cyclosporine and Cardiomegaly
Article | Year |
---|---|
[Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target].
Topics: Animals; Calcineurin; Cardiomegaly; Cyclosporine; Gene Expression; Humans; Immunosuppressive Agents; NFATC Transcription Factors; Signal Transduction; Tacrolimus | 2006 |
Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT.
Topics: Amino Acid Sequence; Animals; Calcineurin; Calcineurin Inhibitors; Calcium; Calcium Signaling; Cardiomegaly; Cyclosporine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Immunosuppressive Agents; Mice; Models, Biological; Molecular Sequence Data; Multigene Family; Myocardium; NFATC Transcription Factors; Nuclear Proteins; Organ Specificity; Protein Isoforms; Sequence Alignment; Sequence Homology, Amino Acid; Signal Transduction; Tacrolimus; Transcription Factors; Transfection | 1999 |
Cardiac hypertrophy: sorting out the circuitry.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; DNA-Binding Proteins; Humans; MAP Kinase Signaling System; NFATC Transcription Factors; Nuclear Proteins; Transcription Factors | 1999 |
Calcineurin and beyond: cardiac hypertrophic signaling.
Topics: Amino Acid Sequence; Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cell Nucleus; Cyclosporine; Cytoplasm; DNA-Binding Proteins; Enzyme Activation; Enzyme Inhibitors; Immunosuppressive Agents; Mice; Mice, Transgenic; Models, Animal; Molecular Sequence Data; NFATC Transcription Factors; Nuclear Proteins; Signal Transduction; T-Lymphocytes; Tacrolimus; Transcription Factors; Transcription, Genetic | 2000 |
Calcineurin inhibition and cardiac hypertrophy: a matter of balance.
Topics: A Kinase Anchor Proteins; Adaptor Proteins, Signal Transducing; Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Carrier Proteins; Cyclosporine; DNA-Binding Proteins; Humans; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Muscle Proteins; Phosphoproteins; Tacrolimus | 2001 |
Calcineurin and hypertrophic heart disease: novel insights and remaining questions.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Heart Failure; Humans; Signal Transduction; Tacrolimus | 2002 |
1 trial(s) available for cyclosporine and Cardiomegaly
Article | Year |
---|---|
Ventricular adrenomedullin is associated with myocyte hypertrophy in human transplanted heart.
Topics: Adolescent; Adrenomedullin; Adult; Aged; Biopsy; Blood Pressure; Cardiomegaly; Cell Size; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Heart Ventricles; Humans; Immunohistochemistry; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Peptides | 2003 |
45 other study(ies) available for cyclosporine and Cardiomegaly
Article | Year |
---|---|
Molecular mechanisms regarding potassium bromate‑induced cardiac hypertrophy without apoptosis in H9c2 cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Animals; Apoptosis; Bromates; Calcineurin; Cardiomegaly; Cell Line; Cell Size; Cyclosporine; Gene Expression Regulation; Humans; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Rats; Reactive Oxygen Species; Signal Transduction | 2018 |
COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Topics: Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclosporine; Dinoprostone; Endothelin-1; Gene Expression Regulation; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Nitrobenzenes; Primary Cell Culture; Promoter Regions, Genetic; Protein Binding; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Sulfonamides; Transcription, Genetic | 2014 |
Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
Topics: Adenoviridae; Angiotensin II; Animals; Animals, Newborn; Aorta; Atrial Natriuretic Factor; Calcineurin; Calpain; Cardiomegaly; Constriction, Pathologic; Cyclosporine; Gene Expression Regulation; Genetic Vectors; Glycoproteins; Imidazoles; Mice; Muscle Proteins; Myocytes, Cardiac; Myosin Heavy Chains; Nuclear Proteins; Primary Cell Culture; Protein Transport; Rats; Repressor Proteins; RNA, Small Interfering; Signal Transduction; Tetrazoles | 2014 |
Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
Topics: Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Cell Nucleus; Cell Size; Cyclosporine; Endothelin-1; Myocytes, Cardiac; NFATC Transcription Factors; PPAR gamma; Protein Biosynthesis; Protein Transport; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Surface Properties; Thiazolidinediones | 2008 |
Blockade of calcineurin reverses cardiac hypertrophy and induces the down-regulation of JNK mRNA expression in renovascular hypertensive rats.
Topics: Animals; Blood Pressure; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Diastole; Down-Regulation; Heart Function Tests; Heart Ventricles; Hypertension, Renovascular; JNK Mitogen-Activated Protein Kinases; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Systole | 2008 |
Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy.
Topics: Animals; Cardiomegaly; Cell Death; Cell Survival; Cyclophilins; Cyclosporine; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxygen Consumption; Peptidyl-Prolyl Isomerase F; Protein Binding; Protein Transport; Rats; Reactive Oxygen Species; Stress, Physiological | 2009 |
Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
Topics: Animals; Calcineurin; Cardiomegaly; Carrier Proteins; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NFATC Transcription Factors; Phosphotransferases (Alcohol Group Acceptor); Physical Conditioning, Animal; Proto-Oncogene Proteins c-akt; Receptors, Adrenergic, alpha-2; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2009 |
Exercise training as a treatment for heart failure: potential mechanisms and clinical implications.
Topics: Animals; Calcineurin; Cardiomegaly; Carrier Proteins; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NFATC Transcription Factors; Phosphotransferases (Alcohol Group Acceptor); Physical Conditioning, Animal; Proto-Oncogene Proteins c-akt; Receptors, Adrenergic, alpha-2; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2009 |
Going out on a LIM and cysteine-rich domains 1 limb: a new way to block calcineurin activity.
Topics: Animals; Binding Sites; Calcineurin; Cardiomegaly; Cyclosporine; Cysteine; Disease Models, Animal; DNA-Binding Proteins; Gene Expression Regulation; Homeodomain Proteins; Humans; Male; Mice | 2010 |
LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
Topics: Animals; Blotting, Northern; Blotting, Western; Calcineurin; Cardiomegaly; Cells, Cultured; Cyclosporine; Disease Models, Animal; Drug Delivery Systems; Gene Expression Regulation; Homeodomain Proteins; LIM-Homeodomain Proteins; Mice; Mice, Transgenic; Myocytes, Cardiac; NFATC Transcription Factors; Random Allocation; RNA, Messenger; Signal Transduction; Transcription Factors; Transfection | 2010 |
Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
Topics: Analysis of Variance; Animals; Blotting, Western; Calcineurin; Cardiomegaly; Cells, Cultured; Cyclosporine; Enzyme Inhibitors; Mice; MicroRNAs; Myocardium; Myocytes, Cardiac; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Statistics, Nonparametric; Transfection | 2010 |
The calcineurin-myocyte enhancer factor 2c pathway mediates cardiac hypertrophy induced by endoplasmic reticulum stress in neonatal rat cardiomyocytes.
Topics: Animals; Animals, Newborn; Apoptosis; Blotting, Western; Calcineurin; Calcium; Cardiomegaly; Cell Size; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Enzyme Inhibitors; Fluorescent Antibody Technique; L-Lactate Dehydrogenase; MEF2 Transcription Factors; Myocytes, Cardiac; Myogenic Regulatory Factors; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Thapsigargin; Tunicamycin | 2010 |
Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy.
Topics: Acetylation; Age Factors; Aging; Amino Acid Sequence; Animals; Cardiomegaly; Cyclophilins; Cyclosporine; Disease Models, Animal; Humans; Lysine; Mice; Mice, 129 Strain; Mice, Knockout; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Myocytes, Cardiac; Peptidyl-Prolyl Isomerase F; Protein Conformation; Sirtuin 3; Structure-Activity Relationship; Time Factors | 2010 |
Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes.
Topics: Adenoviridae; Animals; Animals, Newborn; Calcineurin; Calcium Signaling; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cyclosporine; Disease Models, Animal; LEOPARD Syndrome; Mutation; Myocytes, Cardiac; Noonan Syndrome; Proto-Oncogene Proteins c-raf; ras Proteins; Rats; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; T-Lymphocytes | 2011 |
Role of endothelin in the induction of cardiac hypertrophy in vitro.
Topics: Analysis of Variance; Animals; Benzylamines; Boron Compounds; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cyclosporine; Endothelins; Immunoblotting; In Vitro Techniques; Indoles; Kinetics; Maleimides; Mitogen-Activated Protein Kinases; Myocardial Contraction; NFATC Transcription Factors; Rabbits; Signal Transduction; Sulfonamides; Thiourea; Time Factors | 2012 |
Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant.
Topics: Adult; Autopsy; Body Weight; Cardiomegaly; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Organ Size; Tacrolimus | 2002 |
Cardiac hypertrophy postliver transplantation: a role for FK506 and cyclosporine A?
Topics: Adrenal Cortex Hormones; Autopsy; Cardiomegaly; Cyclosporine; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Tacrolimus | 2002 |
Time-dependent systolic and diastolic function in mice overexpressing calcineurin.
Topics: Animals; Calcineurin; Cardiomegaly; Cyclosporine; Death, Sudden, Cardiac; Diastole; Disease Progression; Echocardiography; Heart; Heart Ventricles; Mice; Mice, Transgenic; Survival Analysis; Systole; Time Factors | 2003 |
Cyclosporin A regulates sodium-calcium exchanger (NCX1) gene expression in vitro and cardiac hypertrophy in NCX1 transgenic mice.
Topics: Animals; Atrial Natriuretic Factor; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Gene Expression Regulation; Humans; In Vitro Techniques; Mice; Mice, Transgenic; Myosin Heavy Chains; Promoter Regions, Genetic; Rats; Recombinant Proteins; Sequence Deletion; Sodium-Calcium Exchanger | 2002 |
Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both?
Topics: Cardiomegaly; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Tacrolimus | 2003 |
Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocytes, Cardiac; Rats; Rats, Wistar; RNA, Messenger | 2001 |
Biventricular hypertrophy in dogs with chronic AV block: effects of cyclosporin A on morphology and electrophysiology.
Topics: Animals; Cardiomegaly; Cyclosporine; Dogs; Electrocardiography; Enzyme Inhibitors; Heart Block; Torsades de Pointes; Ventricular Premature Complexes | 2004 |
Effects of cyclosporine A on angiotensin II-induced cardiomyocyte hypertrophy in neonatal rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcium; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocytes, Cardiac; Proto-Oncogene Proteins c-fos; Rats | 2005 |
Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
Topics: Animals; Calcineurin; Cardiomegaly; Cell Line; Cyclosporine; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Activation; Myocytes, Cardiac; NFATC Transcription Factors; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Tacrolimus | 2006 |
Signaling path may lead to better heart-failure therapies.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiomegaly; Cells, Cultured; Cyclosporine; DNA-Binding Proteins; Enzyme Inhibitors; GATA4 Transcription Factor; Heart Failure; Humans; Mice; Myocardium; NFATC Transcription Factors; Nuclear Proteins; Signal Transduction; Tacrolimus; Transcription Factors | 1998 |
Prevention of cardiac hypertrophy in mice by calcineurin inhibition.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiac Myosins; Cardiomegaly; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Carrier Proteins; Cyclosporine; Female; Mice; Mice, Transgenic; Microfilament Proteins; Models, Cardiovascular; Myocardium; Myosin Light Chains; Rats; Signal Transduction; Tacrolimus; Tropomodulin; Tropomyosin | 1998 |
Calcineurin inhibitors and cardiac hypertrophy.
Topics: Animals; Aorta; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Immunosuppressive Agents; Ligation; Male; Rats; Rats, Sprague-Dawley; Tacrolimus | 1998 |
Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency.
Topics: Adrenergic Antagonists; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Carnitine; Cyclosporine; Disease Models, Animal; Mice; Microtubule-Associated Proteins; Muscle Proteins; Norepinephrine; RNA, Messenger | 1999 |
Calcineurin inhibitors and cardiac hypertrophy.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Humans; Immunosuppressive Agents; Mice; Mice, Transgenic | 1999 |
IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cell Line; Cyclosporine; DNA-Binding Proteins; GATA2 Transcription Factor; Gene Expression Regulation; Hypertrophy; Insulin-Like Growth Factor I; Mice; Mice, Transgenic; Muscle, Skeletal; Myocardium; NFATC Transcription Factors; Nuclear Proteins; Signal Transduction; Transcription Factors | 1999 |
Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.
Topics: Adenoviridae; Animals; Animals, Newborn; Apoptosis; Calcineurin; Cardiac Output, Low; Cardiomegaly; Cells, Cultured; Cyclosporine; Gene Transfer Techniques; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Proteins; Heart; Humans; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Ultrasonography | 2000 |
Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Carrier Proteins; Cyclosporine; Disease Models, Animal; DNA-Binding Proteins; Enzyme Inhibitors; Mice; Mice, Transgenic; Microfilament Proteins; NFATC Transcription Factors; Nuclear Proteins; Phenotype; Transcription Factors; Tropomodulin | 2000 |
Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Disease Progression; Female; Hypertension; Immunosuppressive Agents; Rats; Rats, Sprague-Dawley | 2000 |
Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats.
Topics: Animals; Apoptosis; Cardiomegaly; Cyclosporine; Echocardiography; Fibrosis; Gene Expression; Heart; Heart Failure; Male; Myocardial Infarction; Myocardium; Pressure; Rats; Rats, Wistar; Renin; Ventricular Function, Left; Ventricular Remodeling | 2000 |
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload.
Topics: Acute Disease; Adaptation, Physiological; Animals; Aorta, Thoracic; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Echocardiography; Enzyme Inhibitors; Hemodynamics; Hypertension; Ligation; Male; Mice; Mice, Inbred C57BL | 2000 |
Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiomegaly; Cell Division; Cells, Cultured; Cyclosporine; DNA; Fibroblasts; Fura-2; Hyperplasia; Losartan; Myocardium; Protein Kinase C; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Signal Transduction | 1999 |
[Long-term hemodynamic function of the transplanted heart].
Topics: Cardiomegaly; Cyclosporine; Female; Follow-Up Studies; Heart Rate; Heart Transplantation; Hemodynamics; Humans; Immunosuppressive Agents; Male; Middle Aged; Ventricular Function, Left | 2000 |
Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension.
Topics: Angiotensin II; Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Enzyme Activation; Hypertension, Renovascular; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardium; Protein Kinase C | 2000 |
Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway.
Topics: Animals; Blotting, Western; Calcineurin; Calcineurin Inhibitors; Calcium; Calcium Channels; Cardiomegaly; Cyclosporine; Electrophysiology; Isoproterenol; Kinetics; Mice; Mice, Transgenic; Myocardium; Protein Structure, Tertiary; Ryanodine | 2001 |
Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes.
Topics: Animals; Animals, Newborn; Calcimycin; Calcineurin; Cardiomegaly; Cell Cycle Proteins; Cell Line; Cells, Cultured; Chlorocebus aethiops; COS Cells; Cyclosporine; Dual Specificity Phosphatase 1; Fibroblasts; Gene Expression Regulation, Enzymologic; Heart; Immediate-Early Proteins; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phosphoprotein Phosphatases; Promoter Regions, Genetic; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Transfection | 2001 |
[Involvement of calcineurin-dependent signal pathway in the angiotensin II-induced cardiac myocyte hypertrophy].
Topics: Angiotensin II; Animals; Calcineurin; Cardiomegaly; Cells, Cultured; Cyclosporine; Myocardium; Rats; Signal Transduction | 1999 |
Electrical remodeling in pressure-overload cardiac hypertrophy: role of calcineurin.
Topics: Action Potentials; Animals; Calcineurin; Calcineurin Inhibitors; Calcium; Cardiomegaly; Cells, Cultured; Cyclosporine; Electric Conductivity; Male; Mice; Mice, Inbred C57BL; Myocardium; Patch-Clamp Techniques; Potassium; Pressure; Ventricular Function, Left; Ventricular Remodeling | 2001 |
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
Topics: Animals; Calcineurin; Cardiomegaly; Cyclosporine; Enzyme Inhibitors; Female; Muscle, Skeletal; Muscular Atrophy; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases; Signal Transduction; TOR Serine-Threonine Kinases | 2001 |
Angiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats.
Topics: Angiotensin II; Animals; Blotting, Northern; Body Weight; Calcineurin; Calcium; Cardiomegaly; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hypertrophy; Myocardium; Organ Size; Rats; Rats, Wistar; RNA; Signal Transduction; Up-Regulation | 2001 |
Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.
Topics: Aldosterone; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Body Weight; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Collagen Type III; Cyclosporine; Enzyme Inhibitors; Fibrosis; Heart; Immunosuppressive Agents; Losartan; Male; Mineralocorticoids; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Inbred WKY; RNA, Messenger; Sodium Chloride, Dietary; Tacrolimus | 2002 |